MILC: A Comprehensive Mobile Application That Addresses the Breastfeeding Challenges of Low-income Hispanic Mothers
MILC
Multi-modal Intervention for Lactation Care (MILC)
2 other identifiers
interventional
178
1 country
3
Brief Summary
The innovative platform MILC is designed to provide an integrated and comprehensive professional and social support network with personalized breastfeeding (BF) education to target exclusive breastfeeding (EBF) and any BF behaviors in low-income Hispanic women. Formative research conducted for the development of MILC and results from pilot testing will help guide the completion of the development and testing of this prototype that specifically caters to Hispanic women. In the long term, MILC has the potential to increase the rates of EBF and any BF up to 12 months.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable
Started Aug 2024
Shorter than P25 for not_applicable
3 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
July 20, 2024
CompletedFirst Posted
Study publicly available on registry
July 25, 2024
CompletedStudy Start
First participant enrolled
August 1, 2024
CompletedPrimary Completion
Last participant's last visit for primary outcome
February 1, 2025
CompletedStudy Completion
Last participant's last visit for all outcomes
June 1, 2025
CompletedJuly 26, 2024
July 1, 2024
6 months
July 20, 2024
July 24, 2024
Conditions
Keywords
Outcome Measures
Primary Outcomes (2)
Exclusive breastfeeding
Investigators will assess if participants are breastfeeding exclusively (EBF)through monthly self-reported information. Investigators will record information on EBF at 1 month, 3 months and 6 months among women in the intervention arm.
1 month, 3 months and 6 months
Any breastfeeding rate(EBF)
Investigators will assess if participants are continuous breastfeeding through monthly breastfeeding videos uploaded in the system. Investigators will report information on any breastfeeding at 1 month, 3 months and 6 months.
1 month, 3 months and 6 months
Secondary Outcomes (2)
Infant weight (Medical outcomes)
Baseline, 1 month, 3 months and 6 months
Emergency department visit (Medical outcomes)
Baseline, 1 month, 3 months and 6 months
Other Outcomes (8)
Latching
Baseline, 1 month, 3 months and 6 months
BF history & attitudes questionnaire
Baseline, 1 month, 3 months and 6 months
Self-Efficacy Scale
Baseline, 1 month, 3 months and 6 months
- +5 more other outcomes
Study Arms (2)
Intervention group: MILC application
EXPERIMENTALEligible Hispanic participants in their third trimester will be recruited for the study. The intervention group will receive standard WIC services plus the MILC application.
Control Group: Usual Care
EXPERIMENTALParticipants in the control group will receive care as usual with standard breastfeeding services from the WIC program.
Interventions
Eligible Hispanic participants in their third trimester will be recruited for the study. Intervention group will receive standard WIC services plus the MILC application. Standard WIC support includes on-site lactation consultation, bilingual peer counseling, weekly peer support meetings, free breast pump, and enhanced food package for BF mothers. If a participant has trouble with breastfeeding, she will be referred to a home-visiting breastfeeding peer counselor in the area. Participants will be asked to participate in the periodic follow-up assessments at 1, 3 and 6 months along with demonstrating breastfeeding via MILC app. Participants will send in 1 BF video per month using the MILC app to verify continued BF and fill out monthly self-report to verify EBF. Participants in the incentive group will receive escalating monthly points as incentives for every additional month of continued BF and EBF.
Participants in the control group will receive care as usual with standard breastfeeding services from the WIC program and will be asked to participate in the periodic follow-up assessments at 1, 3 and 6 months. Participants in the control group can receive financial compensation for the completion of assessments. This is necessary to maximize retention and adherence to the monthly assessment schedule, provide comparable remuneration as the incentive group, and minimize demoralization of control group participants following treatment assignment. All participants are informed of the differential group procedures during the randomization consent process. In addition to the follow-up assessment, control group will also complete a monthly self-report on BF status (both for EBF and "any BF"). For attention control purposes in this group, participants will be referred to a mobile app for tracking the baby's milestones called Baby Connect.
Eligibility Criteria
You may qualify if:
- Mothers who successfully exclusively breastfed for up to 6 months, at least one child OR mothers who attempted EBF but were unsuccessful at breastfeeding, in the past 3 years
- Self-identify as Hispanic
- Be WIC-eligible
- Voluntarily consent
- Speak English
- In their late third trimester (approximately 4 weeks from delivery)
- Can initiate BF immediately
- Self-identify as Hispanic
- Be WIC-eligible
- Voluntarily consent
- Not have psychiatric hospitalization within the last 3 months
- Not have current or suicidal thoughts or past attempts
- Own a smartphone device
- Speak English
You may not qualify if:
- Participants who are under the age of 18 or over 44
- Women experiencing a fetal demise or infant death
- Women who report the following conditions also will be excluded:
- Human immunodeficiency virus (HIV)
- Taking antiretroviral medication or chemotherapy agents
- Untreated, active tuberculosis
- T-Cell lymphotropic virus type I or type II
- Illicit drug use
- Receiving radiation therapy
- Exposed to anthrax
- Undergone breast surgery
- Known exposure to environmental toxins
- Active hepatitis B and C
- Prescription drug use incompatible with lactation
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Benten Technologies, Inc.lead
- RTI Internationalcollaborator
- Temple Universitycollaborator
- National Institute on Minority Health and Health Disparities (NIMHD)collaborator
- UConn Healthcollaborator
Study Sites (3)
UCONN Health
Farmington, Connecticut, 06030-8084, United States
RTI International
Research Triangle Park, North Carolina, 27709-2194, United States
Temple University
Philadelphia, Pennsylvania, 19134, United States
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Tony Ma, MS
Benten Technologies
- PRINCIPAL INVESTIGATOR
Yukiko Washio, PhD
RTI International
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- SUPPORTIVE CARE
- Intervention Model
- PARALLEL
- Sponsor Type
- INDUSTRY
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Project Director or Principal Investigator
Study Record Dates
First Submitted
July 20, 2024
First Posted
July 25, 2024
Study Start
August 1, 2024
Primary Completion
February 1, 2025
Study Completion
June 1, 2025
Last Updated
July 26, 2024
Record last verified: 2024-07
Data Sharing
- IPD Sharing
- Will not share